Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas
Cancer, 06/15/09
Nakamura T et al. - Lung RF ablation is a safe and useful therapeutic option for selected patients. (R#1) Prognostic factors identified in study will help to stratify those patients who may benefit from lung RF ablation.
Related Articles
Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas
Modern Pathology, 11/11/09
Relevance Score: 46%
Histiocytic sarcoma with interdigitating dendritic cell differentiation: A case report with fine needle aspiration cytology and review of literature
Diagnostic Cytopathology, 10/28/09
Relevance Score: 45%
Skeletal metastasis from sarcoma: a report of three cases
European Journal of Orthopaedic Surgery & Traumatology, 10/23/09
Relevance Score: 45%
Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09
Relevance Score: 45%
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report
Medical Oncology, 10/19/09
Relevance Score: 45%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
The Oncologist, 12/02/09
Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy
The Oncologist, 12/02/09
Pulmonary neuroendocrine neoplasms: A review of clinicopathologic and cytologic features
Diagnostic Cytopathology, 12/02/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Breast Cancer Research and Treatment, 12/02/09
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action
Breast Cancer Research and Treatment, 12/02/09
FDA Drug Approval Summary: Bevacizumab (Avastin) as Treatment of Recurrent Glioblastoma Multiforme
The Oncologist, 12/02/09
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Current Approach to Pediatric Soft Tissue Sarcomas
The Oncologist, 12/02/09
Metastatic retinoblastoma presenting as a left shoulder soft tissue mass: FNA findings and review of the literature
Diagnostic Cytopathology, 12/01/09
TP53 Codon 72 Polymorphism in Classic, Endemic and Epidemic Kaposi's Sarcoma in African and Caucasian Patients
Oncology (Karger), 11/30/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


